Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
- Year: 2020
- Scope: 2016-2026
- Region: China
- Pages: 131
- Published Date: 02/20/2020
- Type: MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026.
Throughout this medical market research, we analyzed 28 orthobiologics companies across China and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the Chinese Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Orthobiologics Procedure Volumes
- Market Forecasts Until 2026, and Historical Data to 2016
- Competitive Analysis with Market Shares for Each Segment
- Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
- Recent Mergers & Acquisitions
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Market Value and Industry Trends
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 12% of the Chinese population was aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.
In the past, lower-tier hospitals (I and II) were primarily served by local manufacturers with relatively simple products at significantly lower prices than the products purchased by tier III hospitals, which were primarily supplied by international companies. Now, with the financial and regulatory support of the government, increasingly difficult entry barriers for international products and weak intellectual property protection that incentivizes product plagiarism, the market has shifted in favor of local manufacturers.
Competitive Analysis
By 2020, the leading competitor in the Chinese orthopedic biomaterials market was Kunming Baker Norton, which was attributed to its leading position in the HA viscosupplementation market. Kunming Baker Norton’s portfolio includes the five-injection ARTZ® product line, which is originally manufactured by Seikagaku.
Haohai Biologic Technology was the second-leading competitor in the Chinese market. The company held the second-leading position in the three-injection HA viscosupplementation market and the third-leading position in the five-injection HA viscosupplementation market.
Segments Covered
Click on each title to view more detailed market segmentation.
- Procedure Volumes for Orthopedic Biomaterials Devices – MedPro – The Complete procedural analysis for each segment of the Chinese Orthopedic Biomaterials market.
- Orthopedic Bone Graft Substitute Market – MedCore – This market is further segmented by Material Type, including Allograft, Demineralized Bone Matrix Allograft, and Synthetic. Each of these Material Types is segmented by Spine, Trauma, Large Joint Reconstruction, Craniomaxillofacial, and Oncology.
- Orthopedic Growth Factor Market – MedCore – In-depth analysis of the Orthopedic Growth Factor market.
- Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Three-Injection and Five-Injection.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS I
LIST OF FIGURES V
LIST OF CHARTS VII
EXECUTIVE SUMMARY 1
1.1 CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
1.2 COMPETITIVE ANALYSIS 3
1.3 MARKET TRENDS 5
1.4 KEY MARKET DEVELOPMENTS 6
1.5 PROCEDURE NUMBERS 7
1.6 MARKETS INCLUDED 7
1.7 KEY REPORT UPDATES 8
1.8 VERSION HISTORY 8
RESEARCH METHODOLOGY 9
2.1 RESEARCH SCOPE 9
2.2 IDATA’S 9-STEP METHODOLOGY 9
Step 1: Project Initiation & Team Selection 9
Step 2: Prepare Data Systems and Perform Secondary Research 11
Step 3: Preparation for Interviews & Questionnaire Design 12
Step 4: Performing Primary Research 13
Step 5: Research Analysis: Establishing Baseline Estimates 15
Step 6: Market Forecast and Analysis 16
Step 7: Identify Strategic Opportunities 18
Step 8: Final Review and Market Release 19
Step 9: Customer Feedback and Market Monitoring 20
CHINESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 21
3.1 INTRODUCTION 21
3.1.1 Bone Graft Substitutes 21
3.1.2 Hyaluronic Acid Viscosupplementation 22
3.1.3 Growth Factors 22
3.2 CURRENCY EXCHANGE RATES 23
3.3 MARKET OVERVIEW 24
3.4 TREND ANALYSIS 28
3.5 DRIVERS AND LIMITERS 30
3.5.1 Market Drivers 30
3.5.2 Market Limiters 31
3.6 COMPETITIVE ANALYSIS 33
3.7 MERGERS AND ACQUISITIONS 38
PROCEDURE NUMBERS 41
4.1 BONE GRAFT SUBSTITUTE PROCEDURE NUMBERS 41
4.1.1 Bone Graft Substitute Procedure Numbers by Material 41
4.1.2 Bone Graft Substitute Procedure Numbers by Indication 44
4.1.2.1 Bone Graft Substitute Units per Procedure by Indication 47
4.2 HYALURONIC ACID VISCOSUPPLEMENTATION PROCEDURE NUMBERS 50
4.2.1 Hyaluronic Acid Viscosupplementation Procedure Numbers by Injection Cycle 50
4.3 ORTHOPEDIC GROWTH FACTOR PROCEDURE NUMBERS 52
4.3.1 Orthopedic Growth Factor Procedure Numbers 52
BONE GRAFT SUBSTITUTE MARKET 55
5.1 INTRODUCTION 55
5.2 MARKET OVERVIEW 56
5.2.1 Bone Graft Substitute Market by Material 56
5.2.2 Bone Graft Substitute Market by Indication 60
5.3 MARKET ANALYSIS AND FORECAST 63
5.3.1 Total Bone Graft Substitute Market 63
5.3.2 Total Bone Graft Substitute Market by Material 66
5.3.2.1 Allograft Bone Graft Substitute Market 66
5.3.2.2 Demineralized Bone Matrix Market 68
5.3.2.3 Synthetic Bone Graft Substitute Market 70
5.3.3 Total Bone Graft Substitute Market by Indication 72
5.3.3.1 Total Spine Market 72
5.3.3.1.1 Cervical Spine Market 74
5.3.3.1.2 Thoracolumbar Spine Market 76
5.3.3.2 Trauma & Reconstruction Market 78
5.3.3.3 Bone Tumor Market 80
5.3.3.4 CMF Market 82
5.4 DRIVERS AND LIMITERS 84
5.4.1 Market Drivers 84
5.4.2 Market Limiters 85
5.5 COMPETITIVE ANALYSIS 87
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 93
6.1 INTRODUCTION 93
6.2 MARKET OVERVIEW 94
6.2.1 Hyaluronic Acid Viscosupplementation Market by Injection Cycle 94
6.3 MARKET ANALYSIS AND FORECAST 98
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 98
6.3.2 Total Hyaluronic Acid Viscosupplementation Market by Injection Cycle 100
6.3.2.1 Single-Injection Hyaluronic Acid Viscosupplementation Market 100
6.3.2.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 101
6.3.2.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 103
6.4 DRIVERS AND LIMITERS 105
6.4.1 Market Drivers 105
6.4.2 Market Limiters 106
6.5 COMPETITIVE ANALYSIS 108
ORTHOPEDIC GROWTH FACTOR MARKET 113
7.1 INTRODUCTION 113
7.2 MARKET ANALYSIS AND FORECAST 114
7.2.1 Orthopedic Growth Factor Market 114
7.3 DRIVERS AND LIMITERS 116
7.3.1 Market Drivers 116
7.3.2 Market Limiters 117
7.4 COMPETITIVE ANALYSIS 119
APPENDIX: LOCAL COMPETITOR DIRECTORY 121
8.1 WEBSITE DIRECTORY 121
ABBREVIATIONS 123
|
|
LIST OF CHARTS
Chart 1 1: Orthopedic Biomaterials Market by Segment, China, 2012 – 2022 2
Chart 1 2: Orthopedic Biomaterials Market Overview, China, 2015 & 2022 2
Chart 3 1: Orthopedic Biomaterials Market by Segment, China, 2012 – 2022 26
Chart 3 2: Orthopedic Biomaterials Market Breakdown, China, 2015 27
Chart 3 3: Orthopedic Biomaterials Market Breakdown, China, 2022 27
Chart 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 – 2022 29
Chart 3 5: Leading Competitors, Orthopedic Biomaterials Market, China, 2015 37
Chart 4 1: Bone Graft Substitute Procedures by Material, China, 2012 – 2022 43
Chart 4 2: Bone Graft Substitute Procedures by Indication, China, 2012 – 2022 46
Chart 4 3: Total Bone Graft Substitute Units Sold per Procedure by Indication (Excluding Autograft), China, 2012 – 2022 49
Chart 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 – 2022 51
Chart 4 5: Orthopedic Growth Factor Procedures, China, 2012 – 2022 53
Chart 5 1: Bone Graft Substitute Market by Material, China, 2012 – 2022 58
Chart 5 2: Bone Graft Substitute Market Breakdown by Material, China, 2015 59
Chart 5 3: Bone Graft Substitute Market Breakdown by Material, China, 2022 59
Chart 5 4: Bone Graft Substitute Market by Indication, China, 2012 – 2022 61
Chart 5 5: Bone Graft Substitute Market Breakdown by Indication, China, 2015 62
Chart 5 6: Bone Graft Substitute Market Breakdown by Indication, China, 2022 62
Chart 5 7: Total Bone Graft Substitute Market, China, 2012 – 2022 65
Chart 5 8: Allograft Bone Graft Substitute Market, China, 2012 – 2022 67
Chart 5 9: Demineralized Bone Matrix Market, China, 2012 – 2022 69
Chart 5 10: Synthetic Bone Graft Substitute Market, China, 2012 – 2022 71
Chart 5 11: Total Spine Market, China, 2012 – 2022 73
Chart 5 12: Cervical Spine Market, China, 2012 – 2022 75
Chart 5 13: Thoracolumbar Spine Market, China, 2012 – 2022 77
Chart 5 14: Trauma & Reconstruction Market, China, 2012 – 2022 79
Chart 5 15: Bone Tumor Market, China, 2012 – 2022 81
Chart 5 16: Bone Tumor Market, China, 2012 – 2022 83
Chart 5 17: Leading Competitors, Bone Graft Substitute Market, China, 2015 92
Chart 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 – 2022 96
Chart 6 2: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2015 97
Chart 6 3: Hyaluronic Acid Viscosupplementation Market Breakdown, China, 2022 97
Chart 6 4: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 99
Chart 6 5: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 102
Chart 6 6: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 104
Chart 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015 111
Chart 7 1: Orthopedic Growth Factor Market, China, 2012 – 2022 115
Chart 7 2: Leading Competitors, Orthopedic Growth Factor Market, China, 2015 120
LIST OF FIGURES
Figure 1 1: Orthopedic Biomaterials Market Share Ranking by Segment, China, 2015 3
Figure 1 2: Companies Researched in this Report, China, 2015 4
Figure 1 3: Factors Impacting the Orthopedic Biomaterials Market by Segment, China 5
Figure 1 4: Recent Events in the Orthopedic Biomaterials Market, China, 2012 – 2015 6
Figure 1 5: Orthopedic Biomaterials Procedures Covered, China, 2015 7
Figure 1 6: Orthopedic Biomaterials Markets Covered, China, 2015 7
Figure 1 7: Key Report Updates, China, 2013 & 2016 8
Figure 1 8: Version History 8
Figure 3 1: Currency Exchange Rates, 2015 23
Figure 3 2: Orthopedic Biomaterials Market by Segment, China, 2012 – 2022 (US$M) 25
Figure 3 3: Orthopedic Biomaterials Market by Segment, China, 2012 – 2022 (CN¥M) 25
Figure 3 4: Growth Rates by Segment, Orthopedic Biomaterials Market, China, 2012 – 2022 29
Figure 3 5: Drivers and Limiters, Orthopedic Biomaterials Market, China, 2015 32
Figure 3 6: Leading Competitors, Orthopedic Biomaterials Market, China, 2015 36
Figure 4 1: Bone Graft Substitute Procedures by Material, China, 2012 – 2022 42
Figure 4 2: Bone Graft Substitute Procedures (Excluding Autograft Procedures) by Indication, China, 2012 – 2022 45
Figure 4 3: Total Bone Graft Substitute Units Sold by Indication (Excluding Autograft), China, 2012 – 2022 (10cc) 48
Figure 4 4: Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle, China, 2012 – 2022 51
Figure 4 5: Orthopedic Growth Factor Procedures, China, 2012 – 2022 52
Figure 5 1: Bone Graft Substitute Market by Material, China, 2012 – 2022 (US$M) 57
Figure 5 2: Bone Graft Substitute Market by Material, China, 2012 – 2022 (CN¥M) 57
Figure 5 3: Bone Graft Substitute Market by Indication, China, 2012 – 2022 (US$M) 60
Figure 5 4: Bone Graft Substitute Market by Indication, China, 2012 – 2022 (CN¥M) 61
Figure 5 5: Total Bone Graft Substitute Market, China, 2012 – 2022 (US$ and CN¥) 65
Figure 5 6: Allograft Bone Graft Substitute Market, China, 2012 – 2022 (US$ and CN¥) 67
Figure 5 7: Demineralized Bone Matrix Market, China, 2012 – 2022 (US$ and CN¥) 68
Figure 5 8: Synthetic Bone Graft Substitute Market, China, 2012 – 2022 (US$ and CN¥) 70
Figure 5 9: Total Spine Market, China, 2012 – 2022 (US$ and CN¥) 72
Figure 5 10: Cervical Spine Market, China, 2012 – 2022 (US$ and CN¥) 74
Figure 5 11: Thoracolumbar Spine Market, China, 2012 – 2022 (US$ and CN¥) 76
Figure 5 12: Trauma & Reconstruction Market, China, 2012 – 2022 (US$ and CN¥) 78
Figure 5 13: Bone Tumor Market, China, 2012 – 2022 (US$ and CN¥) 80
Figure 5 14: CMF Market, China, 2012 – 2022 (US$ and CN¥) 82
Figure 5 15: Drivers and Limiters, Bone Graft Substitute Market, China, 2015 86
Figure 5 16: Leading Competitors, Bone Graft Substitute Market, China, 2015 91
Figure 6 1: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 – 2022 (US$M) 95
Figure 6 2: Hyaluronic Acid Viscosupplementation Market by Injection Cycle, China, 2012 – 2022 (CN¥M) 95
Figure 6 3: Total Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 (US$ and CN¥) 99
Figure 6 4: Three-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 (US$ and CN¥) 101
Figure 6 5: Five-Injection Hyaluronic Acid Viscosupplementation Market, China, 2012 – 2022 (US$ and CN¥) 103
Figure 6 6: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, China, 2015 107
Figure 6 7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, China, 2015 110
Figure 7 1: Orthopedic Growth Factor Market, China, 2012 – 2022 (US$ and CN¥) 114
Figure 7 2: Drivers and Limiters, Orthopedic Growth Factor Market, China, 2015 118
Figure 7 3: Leading Competitors, Orthopedic Growth Factor Market, China, 2015 119
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Related Reports
